Literature DB >> 9065700

The inhibitory effect of anti-adhesion molecule antibodies on eosinophil infiltration in cutaneous late phase response in Balb/c mice sensitized with ovalbumin (OVA).

J Hakugawa1, S J Bae, Y Tanaka, I Katayama.   

Abstract

In this study, we investigated the involvement of the adhesion molecules intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), very late activation antigen-4 (VLA-4), lymphocyte function-associated antigen 1 (LFA-1) and macrophage antigen-1 (Mac-1) on eosinophil infiltration in the cutaneous late phase response (LPR) in OVA-sensitized Balb/c mice by two approaches, immunostaining and inhibition assays with each monoclonal antibody. The eosinophil infiltration into the skin reached a peak at 12 hr after an intradermal challenge with OVA. Infiltrated eosinophils and mononuclear cells in the skin expressed Mac-1 (eosinophils: 38.9 +/- 1.55%, mononuclear cells: 51.2 +/- 2.15%), LFA-1 (eosinophils: 33.3 +/- 0.95%, mononuclear cells: 23.1 +/- 1.07%) and VLA-4 (eosinophils: 14.3 +/- 1.6%, mononuclear cells: 17.2 +/- 1.38%) at 12 h. Intraperitoneal administration of anti-mouse ICAM-1, VCAM-1, and VLA-4 monoclonal antibodies (mAb) before the challenge decreased the eosinophil infiltration by 66.2%, 61.0%, and 54.0%, respectively. On the other hand, pretreatment with anti-mouse LFA-1 mAb or Mac-1 mAb did not significantly decrease the infiltration. These results suggest that VCAM-1/VLA-4 interaction and ICAM-1 play important roles in eosinophil infiltration in cutaneous LPR.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065700     DOI: 10.1111/j.1346-8138.1997.tb02747.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  9 in total

Review 1.  Isoforms of vitamin E differentially regulate inflammation.

Authors:  Joan M Cook-Mills; Christine A McCary
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-12       Impact factor: 2.895

2.  VCAM-1 induces signals that stimulate ZO-1 serine phosphorylation and reduces ZO-1 localization at lung endothelial cell junctions.

Authors:  Hiam Abdala-Valencia; Timothy S Kountz; Michelle E Marchese; Joan M Cook-Mills
Journal:  J Leukoc Biol       Date:  2018-06-11       Impact factor: 4.962

Review 3.  Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants.

Authors:  Joan M Cook-Mills; Michelle E Marchese; Hiam Abdala-Valencia
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

4.  Endothelial cell PTP1B regulates leukocyte recruitment during allergic inflammation.

Authors:  Sergejs Berdnikovs; Hiam Abdala-Valencia; Joan M Cook-Mills
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-12-28       Impact factor: 5.464

5.  Nonhematopoietic NADPH oxidase regulation of lung eosinophilia and airway hyperresponsiveness in experimentally induced asthma.

Authors:  Hiam Abdala-Valencia; Julie Earwood; Shelly Bansal; Michael Jansen; George Babcock; Beth Garvy; Marsha Wills-Karp; Joan M Cook-Mills
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-02-09       Impact factor: 5.464

6.  Asthma, allergy and vitamin E: Current and future perspectives.

Authors:  Joan M Cook-Mills; Samantha H Averill; Jacquelyn D Lajiness
Journal:  Free Radic Biol Med       Date:  2021-11-14       Impact factor: 8.101

Review 7.  Hydrogen peroxide activation of endothelial cell-associated MMPs during VCAM-1-dependent leukocyte migration.

Authors:  Joan M Cook-Mills
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2006-12-31       Impact factor: 1.770

8.  Isoforms of Vitamin E Differentially Regulate PKC α and Inflammation: A Review.

Authors:  Joan M Cook-Mills
Journal:  J Clin Cell Immunol       Date:  2013-03-14

9.  Urine Proteomic Study in OAB Patients-Preliminary Report.

Authors:  Konrad Futyma; Łukasz Nowakowski; Alicja Ziętek-Strobl; Aleksandra Kamińska; Nadia Taoussi; Tomasz Rechberger
Journal:  J Clin Med       Date:  2020-05-08       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.